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The mosquito-borne arbovirus Zika virus (ZIKV, Flavivirus, Flaviviridae), has caused an outbreak
impressive by its magnitude and rapid spread. First detected in Uganda in Africa in 1947, from where it
spread to Asia in the 1960s, it emerged in 2007 on the Yap Island in Micronesia and hit most islands in
the Pacific region in 2013. Subsequently, ZIKV was detected in the Caribbean, and Central and South
America in 2015, and reached North America in 2016. Although ZIKV infections are in general asymp-
tomatic or causing mild self-limiting illness, severe symptoms have been described including neuro-
logical disorders and microcephaly in newborns. To face such an alarming health situation, WHO has
declared Zika as an emerging global health threat. This review summarizes the literature on the main
vectors of ZIKV (sylvatic and urban) across all the five continents with special focus on vector compe-
tence studies.
© 2018 The Authors. Published by Elsevier Masson SAS on behalf of Institut Pasteur. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Zika virus (ZIKV) belongs to the genus Flavivirus in the family
Flaviviridae. Within the Flavivirus genus, ZIKV is a mosquito-borne
virus phylogenetically close to Japanese encephalitis (JEV), West
Nile (WNV), dengue (DENV), and yellow fever (YFV) viruses [1].
Discovered in Uganda in 1947 [2], ZIKV emerged outside Africa in
Asia after 1960. It caused the first major outbreak in Yap Island in
2007 [3,4], spread to French Polynesia [5] and other Pacific islands
in 2013e2014 [6e8], reached Latin America in 2013e2015 [9,10],
and ended up affecting more than 30 American countries (https://
wwwnc.cdc.gov/travel/page/world-map-areas-with-zika). Thus,
with the exception of Europe, ZIKV has circulated on all continents
(Fig. 1).
ZIKV strains can be grouped into three main lineages: East Af-
rican, West African, and Asian [11]. It is a 50-nm enveloped virus
with an inner nucleocapsid and an outer lipid bilayer. The inner
nucleocapsid is composed of a linear positive-sense, single-
stranded RNA virus of 10,794-nucleotides (nt) and multiple copiesB. Failloux).
er Masson SAS on behalf of Instit
t al., An overview of mosquitoof the viral capsid (C) protein. The outer lipid bilayer derived from
the host cell is covered by 180 copies of two proteins: the viral
membrane M protein and the envelope (E) protein [12]. The
genomic RNA comprises a single open reading frame (ORF) flanked
by 30 and 50 non-coding regions. The ORF encodes a large poly-
protein cleaved into 10 proteins: 3 structural proteins (C, prM, E)
and 7 non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B,
and NS5). The viral RNA replication cycle occurs in the cell cyto-
plasm. The Asian lineage has been responsible for the current
global expansion of ZIKV [4,11,13].
ZIKV is transmitted to humans mainly through the bite of
infected mosquitoes. The two main transmission cycles are (Fig. 2):
(i) a sylvatic cycle between non-human primates and arboreal
canopy-dwelling mosquitoes (Ae. africanus, Ae. bromeliae, Ae. dal-
zieli, Ae. furcifer, Ae. luteocaphalus, Ae. opok, Ae. taylori, Ae. uni-
lineatus, Ae. vittatus…) and (ii) an urban cycle with humans as both
reservoir and amplification hosts, and anthropophilic mosquitoes
as vectors (primarily, Aedes aegypti and secondarily, Aedes albo-
pictus; Fig. 1). The implication of Ae. aegypti as the main vector is
supported by repeated isolation of ZIKV from field-collected
mosquitoes [14e18] (Table 1) and experimental evidence of
ability to transmit ZIKV [19e29] (Table 2). Ae. albopictus has
been suggested to be involved in transmission as ZIKV has beenut Pasteur. This is an open access article under the CC BY-NC-ND license (http://
vectors of Zika virus, Microbes and Infection (2018), https://doi.org/
Fig. 1. Countries with reporting symptomatic ZIKV cases and geographic distribution of Ae. aegypti and Ae. albopictus.
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Fig. 2. Vector- and Non-vector-borne transmissions of ZIKV. Vector-borne cycles comprise a sylvatic cycle with a viral circulation between non-human primates and zoophilic
mosquitoes, and an urban cycle with humans as reservoir and amplification hosts and anthropophilic mosquitoes as vectors. Non-vector borne mode involves direct human-to-
human transmission by contacts of fluids.
Table 1
Mosquito species found naturally infected with ZIKV.
Country Sites/Localities Years Mosquito species Reference
AFRICA Senegal Saboya, Bandia, Kedougou 1968e69, 1972, 1974, 77, 1980e81,
1985e89, 1991e92, 1994, 1997e99,
2001e03, 2011 and 2015
Ae. aegypti, Ae. africanus, An. coustani, An. gambiae,
Cx. perfuscus, Ma. uniformis, Ae. dalzieli, Ae. fowleri,
Ae. furcifer, Ae. hirsutus, Ae. luteocephalus, Ae. metallicus,
Ae. neoafricanus, Ae. taylori, Ae. unilineatus, Ae. vittatus,
An. coustani, An. gambiae, Cx. perfuscus, Ma. uniformis
[112]
[14]
Ivory
coast
Dabakala, Kong, Touba,
Odieme, Taï, Kakpin
1973, 1975, 1979, 1980e82 and 1999 Ae. aegypti, Ae. africanus, Ae. flavicollis, Ae. furcifer,
Ae. grahami, Ae. luteocephalus, Ae. opok, Ae. taeniarostris,
Ae. vittatus, Er. Quinquevittatus, Er. Inornatus
[84]
[194]
Burkina
Faso
forest gallery of Dinderesso,
Fada Ngourm, Bobodioulasso,
Yabasso
1978 and 1983 Ae. aegypti, Ae. furcifer, Ae. jamoti, Ae. luteocephalus,
Ae. opok
[116]
[195]
Central
African
Republic
Gomoka, Bouboui, Bozo 1968, 1976 and 1979 Ae. africanus, Ae. opok [111]
Uganda Zika forest Lunyo forest 1948, 1956, 1958,1962e64, 1969e70 Ae. africanus, Ae. apicoargenteus [62]
[2]
[113]
[114]
[115]
Nigeria Small forest near Tagwe 1969 Ae. luteocephalus [117]
Gabon Libreville (Nzeng-Ayong and
Alenkri suburbs)
2007 Ae. albopictus [30]
ASIA Malaysia Bentong 1966 Ae. aegypti [15]
AMERICA Mexico Guerrero state 2015 Ae. aegypti [18]
Brazil Rio de Janeiro 2015e2016 Ae. aegypti [16]
Bahia 2015 Ae. albopictus [31]
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Table 2
Vector competence of mosquitoes for ZIKV.
Species Mosquitoes tested Titer of blood meal Virus strain Infection Transmission EIP (days) References
Country Locality
AFRICA Aedes aegypti Senegal Dakar 2.7 106e4 107 pfu/mL ArD128000 (Kedougou 1997) þ e e [121]
ArD132912 (Kedougou 1998) þ e e
ArD157995 (Kedougou 2001) þ e e
ArD165522 (Kedougou 2002) þ e e
HD78788 (Dakar 1991) þ e e
MR766 (Uganda 1947) þ e e
Kedougou 2.7 106e4 107 pfu/mL ArD128000 (Kedougou 1997) þ e e [121]
ArD132912 (Kedougou 1998) þ e e
ArD157995 (Kedougou 2001) þ e e
ArD165522 (Kedougou 2002) þ e e
HD78788 (Dakar 1991) þ e e
MR766 (Uganda 1947) þ e e
Kebemer Intrathoracic inoculation ArD24280 (Kedougou 1976) þ þ 7 [112]
Nigeria Ikeja near Lagos 106MLD50/mL ZIKV þ þ 14 [120]
Aedes vittatus Senegal Kedougou 2.7 106e4 107 pfu/mL ArD128000 (Kedougou 1997)
ArD132912 (Kedougou 1998)
ArD157995 (Kedougou 2001)
ArD165522 (Kedougou 2002)
HD78788 (Dakar 1991)
MR766 (Uganda 1947)
þ e e [121]
þ e e
þ e e
þ e e
þ þ 15
þ e e
Aedes luteocephalus Senegal Kedougou 2.7 106e4 107 pfu/mL ArD128000 (Kedougou 1997) þ e e [121]
ArD132912 (Kedougou 1998) þ e e
ArD157995 (Kedougou 2001) þ e e
ArD165522 (Kedougou 2002) þ e e
HD78788 (Dakar 1991) þ e e
MR766 (Uganda 1947) þ þ 15
Aedes unilineatus Senegal Kedougou 2.7 106e4 107 pfu/mL ArD128000 (Kedougou 1997) þ e e [121]
ArD132912 (Kedougou 1998) þ e e
ArD157995 (Kedougou 2001) þ e e
ArD165522 (Kedougou 2002) þ e e
HD78788 (Dakar 1991) þ e e
MR766 (Uganda 1947) þ e e
ASIA Ae. aegypti Singapore Singaporea 107 TCID50/mL MR766 (Uganda 1947) þ þ 4 [19]
10 56 pfu/mL H/PF/2013 (French Polynesia 2013) þ þ 3 [22]
BE H 815744 (Paraiba 2015) þ þ 3
Ae. albopictus Singapore Singaporea 107.5 TCID50/mL MR766 (Uganda 1947) þ þ 4 [32]
10 56 pfu/mL H/PF/2013 (French Polynesia 2013) þ þ ND [22]
BE H 815744 (Paraiba 2015) þ þ ND
Cx. quinquefasciatus China Hainan 3 105 pfu/mL SZ01 (Samoa 2016) þ þ 8 [137]
Singapore Singaporea 10 56 pfu/mL H/PF/2013 (French Polynesia 2013) þ e e
e
[22]
BE H 815744 (Paraiba 2015) þ e
PACIFIC ISLANDS Ae. hensilli Yap state Yap 10 4.9e5.9 pfu/mL MR766 (Uganda 1947) þ ND ND [145]
Ae. aegypti French Polynesia Tahitia 107 TCID50/mL PF13/251013e18 (French Polynesia 2013) þ þ 6 [23]
Australia Townsville 106.7±0.2 TCID50/mL MR766 (Uganda 1947) þ þ 10 [24]
Cairns 105.6 TCID50/mL Cambodia 2010 þ þ 14 [25]
Ae. polynesiensis French Polynesia Tahitia 107 TCID50/mL PF13/251013e18 (French Polynesia 2013) þ e e [23]
Ae. notoscriptus Australia Brisbane 106.7±0.2 TCID50/mL MR766 (Uganda 1947) þ e e [24]
Australia Bellarine 105.6 TCID50/mL Cambodia 2010 þ þ 14 [25]
Ae. vigilax Australia Brisbane 106.7±0.2 TCID50/mL MR766 (Uganda 1947) þ e e [24]
Ae. procax Australia Brisbane 106.7±0.2 TCID50/mL MR766 (Uganda 1947) þ e e [24]
Ae. camptorhynchus Australia Gippsland 105.6 TCID50/mL Cambodia 2010 þ þ 14 [25]
Ae. albopictus Australia Torres Strait Islands 105.6 TCID50/mL Cambodia 2010 þ þ 14 [25]
Cx. quinquefasciatus French Polynesia Tahiti 107 TCID50/mL PF13/251013e18 (French Polynesia 2013) þ e e [146]
Australia Brisbane 106.7±0.2 TCID50/mL MR766 (Uganda 1947) þ e e [24]
Victoriaa 105.6 TCID50/mL Cambodia 2010 e e e [25]
Cx. annulirostris Australia Brisbane 106.7±0.2 TCID50/mL MR766 (Uganda 1947) e e e [24]
Victoriaa 105.6 TCID50/mL Cambodia 2010 e e e [25]
Cx. sitiens Australia Brisbane 106.7±0.2 TCID50/mL MR766 (Uganda 1947) e e e [24]
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AMERICA Ae. aegypti Mexico Poza Rica 104.68.9 pfu/mL HND (2016e19563) (Honduras 2016) þ þ 21 [26]
104.38.7 pfu/mL CAM strain FSS130325 (Cambodia 2010) þ þ 21
Poza Rica 1.6 107 pfu/mL PRVABC59 (Puerto Rico 2015) þ þ 7 [21]
Dakar D41525 (Senegal 1984) þ þ 7
MR766 (Uganda 1947) þ þ 7
Reynosaa 106.46 pfu/mL Zika PF þ þ 4 [35]
Liverpoola 104.746.02 pfu/mL PRVABC59 (Puerto Rico 2015) þ þ 14 [196]
Brazil Rioa 2.3 106 pfu/mL ZIKVPE243 (Recife 2015) e e e [27]
1.68,107 pfu/mL ZIKVSPH (Sao Paulo 2015) e e e
3.55,106 pfu/mL ZIKVU1 (Rio 2015) þ þ 7
Fernando de Noronha 106 pfu/mL BRPE243/2015 (Brazil 2015) þ þ 3 [28]
Recifea 106 pfu/mL BRPE243/2015 (Brazil 2015) þ þ 3 [28]
Ae. albopictus US Suffolk county 104.68.9 pfu/mL HND (2016e19563) (Honduras 2016) þ þ 21 [26]
104.38.7 pfu/mL CAM strain FSS130325 (Cambodia 2010) þ þ 21
Texas 1.6 106e6 108 ffu/mL Dakar 41525 (Senegal 1984) þ þ 3 [33]
4.3 105e2 107 ffu/mL FSS130125 (Cambodia 2010) þ þ 7
3.5 105e107 ffu/mL MEX 1e7 (Mexico 2015) þ þ 7
Houston 6.5 106e1.2 107 ffu/mL PB81 (Brazil 2015) þ þ 7 [33]
7.5 106e2.5 107 ffu/mL PRVABC59 (Puerto Rico 2015) þ þ 3
2 106e1.5 107 ffu/mL MEX 1e7 (Mexico 2015) þ e e
Brazil Salvador 1.4 106e1.2 107 ffu/mL PB81 (Brazil 2015) þ e e [33]
106e1.5 107 ffu/mL MEX 1e7 (Mexico 2015) þ e e
US Missouria 104.746.02 pfu/mL PRVABC59 (Puerto Rico 2015) þ þ 14 [196]
Ae. triseriatus US Iowaa 104.746.02 pfu/mL PRVABC59 (Puerto Rico 2015) þ e e [34]
Ae. taeniorhynchus US Gulf coasta 106 ffu/mL MEX 1e44 (Mexico 2015) e e e [169]
Ae. vexans US Colorado 7 106e1.7 107 pfu/mL PRVABC59 (Puerto Rico 2015) þ þ 14 [171]
Cx. pipiens US Pennsylvaniaa 5 106 pfu/mL PRVABC59 (Puerto Rico 2015) e e e [21]
Iowaa 104.746.02 pfu/mL PRVABC59 (Puerto Rico 2015) e e e [34]
Chicagoa 106 pfu/mL MR766 (Uganda 1947) þ e e [172]
106 pfu/mL PRVABC59 (Puerto Rico 2015) þ e e
Cx. quinquefasciatus US Floridaa 1.6 107e5 106 pfu/mL PRVABC59 (Puerto Rico 2015) þ e e [21]
USa 106 ffu/mL MEX 1e44 (Mexico 2015) e e e [169]
1046 ffu/mL Dakar 41525 (Senegal 1984) e e e
1046 ffu/mL FSS130125 (Cambodia2010) e e e
1046 ffu/mL MEX 1e7 (Mexico 2015) e e e
Houston 1046 ffu/mL FSS130125 (Cambodia 2010) e e e [169]
1046 ffu/mL MEX 1e7 (Mexico 2015) e e e
107 ffu/mL PRVABC59 (Puerto Rico 2015) e e e
USa 107.5 pfu/mL MR766 (Uganda 1947) PRVABC59
(Puerto Rico 2015)
e e e [170]
107.3 pfu/mL e e e
Floridaa 106 pfu/mL MR766 (Uganda 1947) þ e e [172]
1047.1 pfu/mL PRVABC59 (Puerto Rico 2015) e e e
106.47.6 pfu/mL R103451 (Honduras 2016) e e e
Brazil Recife 2.3 106 pfu/mL ZIKVPE243 (Recife 2015) e e e [27]
3.55,106 pfu/mL ZIKVU1 (Rio 2015) þ e e
Campina 2.3 106 pfu/mL ZIKVPE243 (Recife 2015) e e e [27]
3.55,106 pfu/mL ZIKVU1 (Rio 2015) e e e
Triagem (Rio) 2.3 106 pfu/mL ZIKVPE243 (Recife 2015) e e e [27]
Manguinhos (Rio)a 2.3 106 pfu/mL ZIKVPE243 (Recife 2015) e e [27]
Recifea 106 pfu/mL BRPE243/2015 (Brazil 2015) þ þ 7 [28]
Cx. tarsalis US Californiaa 5 106 pfu/mL PRVABC59 (Puerto Rico 2015) e e e [21]
An. gambiae -a 104.67 pfu/mL MR766 (Uganda 1947) e e e [170]
An. stephensi -a 104.37.7 pfu/mL MR766 (Uganda 1947) e e e [170]
EUROPE Ae. aegypti Mexico Reynosaa 106.46 ffu/mL ZIKV FP þ þ 4 [35]
Madeira Funchal 107 TCID50/mL NC-2014-5132 (NC 2014) þ þ 9 [29]
Paulo do Mar 107 TCID50/mL NC-2014-5132 (NC 2014) þ e e [29]
Ae. albopictus Italy Calabria 106.46 ffu/mL ZIKV FP þ þ 11 [35]
France Nice 107 TCID50/mL NC-2014-5132 (NC 2014) þ e e [29]
Bar-sur-Loup 107 TCID50/mL NC-2014-5132 (NC 2014) þ þ 14 [29]
a Lab colony (Generation > 10).
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[30,31] (Table 1), and transmission demonstrated in laboratory
[22,25,26,29,32e35] (Table 2).
The mosquito Ae. aegypti has a worldwide distribution and
colonized most tropical countries. The geographic distribution of
Ae. aegypti globally coincides with the area of dengue transmission.
This mosquito, which breeds mainly in domestic containers [36],
can take several blood-meals before oviposition, thereby increasing
the chances of arbovirus infection and transmission [37]. On the
other hand, Ae. albopictus is an opportunistic day-time and outdoor
feeder, but generally prefers humans and can be found feeding and
resting indoors. Ae. albopictus succeeded in colonizing temperate
zones such as United States [38] and Europe [39], and invaded
African countries where it now acts as a main vector of DENV and
chikungunya virus (CHIKV) in urban [40] and rural settings [41]. In
rare cases, Ae. albopictus can be involved in DENV epidemics (e.g.
Mexico in 1997 [42], Hawaii in 2001 [43]). The species also has
become the main vector of CHIKV in the world [44,45].
ZIKV, as most arboviruses, has the potential to persist in mos-
quito eggs. The virus can be acquired by the progeny by vertical
transmission (VT) from infected mothers through (i) transovarial
transmission when the virus infects germinal tissues in the ovaries
and (ii) trans-egg transmission when infection occurs during
fertilization [46]. VT has been demonstrated in Ae. aegypti and Ae.
albopictus mosquitoes [14,16,31,47,48]. This possibility has already
been suggested by the detection of ZIKV from field-collected Ae.
furcifer males in southeastern Senegal [14].
Venereal transmission is another mechanism by which a virus
can spread in a mosquito population. Males cannot get the virus
from a blood meal but can acquire virus by VT from an infected
female parent. In experimental studies, it has been shown that
infectedmale Ae. aegypti can transmit the virus horizontally to non-
infected adult females during mating. Thus venereal transmission
in Aedes mosquitoes may have a role in the maintenance of ZIKV in
nature (Campos et al. unpublished data).
In addition to vector-borne transmission, direct human-to-
human transmission of ZIKV has been documented (Fig. 2): in
utero from infected mothers to fetus [49], sexually through secre-
tions predominantly from male to female [50e52], through breast
feeding [53], blood transfusion [54e56], saliva [57], urine [58]. The
importance of these non-vector-borne ZIKV transmission routes is
difficult to measure. However, these multiple modes of trans-
mission are unlikely to be as significant as mosquito-borne trans-
mission, as suggested by their negligible effect during seasons not
permissive for mosquito activity.
Beside mild symptoms, ZIKV can cause neurological disorders
such as Guillain-Barre syndrome in adults [59,60] and micro-
cephaly in newborns [61]. Zika has been then declared an emerging
global health threat by the World Health Organization (WHO). In
this review, we will describe the epidemiology of the disease and
the main vectors (sylvatic and urban) with an emphasis on virus
detection from field-collected mosquitoes and studies on vector
competence in the five continents.
2. Africa, the cradle of Zika
The first evidence of ZIKV circulationwas reported in Africa. The
occurrence in humans and other vertebrates was cataloged by re-
ports of outbreaks, sporadic cases and serological studies (Table 3).
2.1. East Africa
In East Africa, ZIKV was detected in many countries: Burundi,
Djibouti, Ethiopia, Kenya, Somalia, Madagascar, Mozambique,
Seychelles, Sudan, Tanzania, Uganda, and Zambia. The first ZIKVPlease cite this article in press as: S. Boyer, et al., An overview of mosquito
10.1016/j.micinf.2018.01.006isolation from a human occurred in Uganda in 1964 [62]. Neutral-
izing antibodies against ZIKV were detected in patients in Uganda
(12.8% of positive samples) and in Tanzania (50%) in 1945, 1947e48
[63]. ZIKV circulationwas then suspected in the Karamoja district of
Uganda in 1967e69 and 1984 [64,65]. In Ethiopia, serological
studies showed ZIKV in 3e60% of human sera collected in 1960 and
6e12% of sera collected in 1961e1964 [66]. In Kenya, antibodies
against ZIKV were detected in Nyanza (3.3% of positive samples),
Kitui (1.3%) and Malindi (52%) in 1964e66 [67]. In Somalia, a
seroprevalence study revealed ZIKV circulation in 1966 [64]. In
Zambia, anti-ZIKV IgG/IgM antibodies were found in 6% of samples
tested in 2013 [68]. ZIKV appears to have circulated in other
countries of East Africa: Mozambique (4% in 1957) [69], Burundi
(1.4% in 1980e82) [70], Djibouti (2.2% in 1991e1992) [71], Sudan
[72], Seychelles (0.7% in 1970) [73] and Madagascar (7.7% in 1977
and 1986) [74,75].
2.2. West and Central Africa
ZIKV was also detected in West and Central Africa: Angola,
Benin, Burkina Faso, Cabo Verde, Cameroon, Central African Re-
public (CAR), Chad, Gabon, Guinea Bissau, Ivory Coast, Liberia, Mali,
Niger, Nigeria, Republic of Congo, Senegal, Sierra Leone, and Togo.
ZIKV was first detected in Senegal in 1962 by hemagglutination
inhibition (HI) in 33% of human sera [76]. Antibodies against ZIKV
were then detected in 1965, 1967, 1970e72, 1972e1976 [77], 1981
[78], 1988 and 1990 [79]. ZIKV was also isolated in humans in 1976
and 1990 in Kedougouwhere seroprevalence studies indicated viral
circulation in 1984, 1995 and 2008 [80]. More recently, ZIKV in-
fections in humans were reported in 2000 and 2013 [81], in 2011
(14 IgM-positive samples in Kedougou) and 2015 (17 samples in
Kedougou and two other localities). A more recent retrospective
study showed that 6.2% of blood samples collected between 1992
and 2016 from Senegal and Nigeria were IgM positive for ZIKV [81].
In Guinea Bissau, a ZIKV serosurvey reported that 11% of human
samples collected in 1964e65 were positive [82]. Lately, ZIKV RNA
was detected in blood samples from six febrile patients in the
Bijagos Islands in 2016. In Ivory Coast, ZIKV circulation was sus-
pected in 1963e65 (6 localities; 20% of positive samples) [83] and
1999 (one locality; 48% of positive samples) [84,85], and ZIKV-
antibodies were detected in 45.3% of patients in 1997e1998 in
Abidjan [85]. In Nigeria, 12.2e55.1% of human samples presented
ZIKV antibodies in Ilobi in 1955 and in other localities in 1966e67
(Robin, in Ref. [83]), [86e89]. ZIKV was isolated from human blood
samples at Ibadan in 1975 [90] and in the state of Igbo Ora-Oyo in
1971e1975 [87,91]. The most recent evidence of ZIKV active circu-
lation was 2011 and 2013 in Jos [81]. In Cabo Verde which was the
scene of the largest urban outbreak of Zika in Africa, 7557 human
cases were reportedmainly in the island of Santiago, Fogo andMaio
in May 2016 [92]. In Gabon, ZIKV circulationwas suspected in 2007
[30], in Libreville and Cocobeach. Libreville had already been
exposed to ZIKV in 1967 (7% of positive samples), 1975 and
1979e80 (14.7%) [77,83,93]. In CAR, higher seroprevalences to ZIKV
were documented in 1961e62 (5 localities; 48.8% of positive cases
among tested ones), 1963e64 (3 localities; 6.9% of positive sam-
ples) and 1979 (1 locality; 26.3e27.4% of positive samples)
[83,94,95]. In Cameroon, 2e10% blood donors were ZIKV-positive
[96] corroborating the repeated exposures of humans to this virus
in 1964e66 [97], 1984 [98,99] and 2015 [100]. In the neighboring
country of Angola, ZIKV was detected in 27% of human sera
collected in 14 localities in 1960 [101]. ZIKV was again detected in
Angola in 1971e72 [102] and in 2016 in Luanda and Bengo province
(detection of a case of microcephy) [103]. In other countries inWest
and Central Africa, ZIKV circulation is suspected in Mali (2 localities
in 1964 and 1967; 52% of positive samples), Burkina Faso (5vectors of Zika virus, Microbes and Infection (2018), https://doi.org/
Table 3
Evidences of Zika virus infection in human and animals in Africa.
Country Host Years Locations Assays References
Senegal Human 1962
1965
1967, 1970e76
1981
1984
1988
1990
1995
2000
2008
2011
2013
2015
1996e2016
Dakar,
Casamance, Ferlo, Region du Fleuve
Diourbel, Sangap, Saboya, Tankon, Kolda
Bandia
Sine Saloum
Panthiou-Sine, Niakhene
Saraya, Kedougou, Dindefello, Fongolimbi,
Tomboronkot, Salemata, Khossanto, Bandafassi
Thies
Mbour, Tambacounda, Velingara
Serology
Isolation
PCR
[76]
[77]
[78]
[79]
[197]
[198]
Cercopithecus aethiops,
Erythrocebus patas, Wild mammals
1967e68
1973, 1976
South-eastern Senegal Serology
Isolation
Chunickin,
in Ref. [77]
[83]
Guinea Bissau Human 1964e65, 2016 Inland, Coast
Bubaque
Serology
PCR
[82]
Mali Human 1964
1967
Nioro du Sahel, Yanfolila Serology [83]
Burkina Faso Human 1963e64 Dori, Banfora, Bobodioulasso, Diebougou, Zignare Serology [83]
Côte d’Ivoire Human 1963e65
1997e99
Bouake, Tiassale, Korhogo, Man, Daloa Sassandra
Abidjan
Comoe National Park
Serology [83]
[84]
[85]
Nigeria Human 1951
1955
1966e67
1971e75
1996e2016
2011, 2013
Ilaro, Iloba,
Imosan, Fugar, Iressa, Ado, Ase, Orhua, Ibadan,
Igbo Ora, Oyo, Jos
Serology
Isolation
PCR
[199]
[88]
[83]
[87]
[90]
[91]
Non-Human Primates 1969, 1971e72 Nupeko forest
Southern Nigeria forest
Serology [200]
Sierra Leone Human 1972 Freetown, Walihun, Sembehun, Sahn Iionia, Pujohun
Malcari and Magburalca Lalehun Labor Camp, Raoma
Kangama, Kayima Bafodia, Koinadugu
Serology [106]
Benin Human 1967 Djougou and Savalou Serology [83]
Liberia Human 1967, 1981e82 Loffa, Grand Bassa Serology [83]
[105]
Pan troglodytes Serology [111]
Togo Human 1964e66 Trevis, Sokode, Pagouda, Niamtougou, Dapango Serology [83]
Niger Human 1965 Tera Serology [83]
Chad Human 1954 Serology [104]
Cabo Verde Human 2015e16 Santiago, Fogo, Maio, Boa Vista Serology, PCR [92]
Gabon Human 1967
1975, 1979e80
2007
Libreville, Coccobeach PCR
Serology
[83]
[30]
[77]
[93]
Non-Human Primates 1979e80 Non-Human Primates Serology [93]
Central African
Republic
Human 1961e64,
1979
Botambi, Obo, Bouar, Bangassou, Kemgribingui
Bangui, Lobaye
Serologyand
Isolation
[83]
[94]
[95]
C. neglectus, C. nictitans, C. aethiops,
Cercocebus sp, Galago demidovi,
Pan troglodytes, Bats, rodents
(Praomys sp, Lophuromys sikapusi,
Anomalurus sp)
1976 Serology [108]
[66]
[110]
[111]
Cameroon Human 1964e66, 1971e72,
1984, 2010, 2015
Maroua, Garoua, Bertoua, Yaounde, Ngaoundere,
Douala, Buco, Limba, Tiko, Muyuka
Serology [96]
[100]
[97]
[98]
[99]
[97]
Democratic Republic
of Congo
Pan troglodytes Serology
Uganda Human 1945, 1947e48,
1952, 1964
1967e69, 1984
Bwamba, Toro, Central, Molambigambo, Karamoja Isolation
Serology
[62]
[63]
[64]
[65]
Macacca mulatta, other
monkeys
1947e48, 1956,
1962e63, 1969e70
Zika forest
Entebbe
Isolation
Serology
[2]
[111]
[112]
(continued on next page)
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Table 3 (continued )
Country Host Years Locations Assays References
Tanzania Human Tanga Serology [63]
[63]
Madagascar Human 1984e86 Ambatomainty, Nosy-Be Serology [201]
[74]
Seychelles Human 1970 Serology [73]
Ethiopia Human 1960e64 Gora, Manera, Goya, Boreda Kocha, Wallamo Kaffa,
Chouchouma Tchabera, Opa, Didessa
Serology [66]
C. guereza, P. cynocephalus
Bats
1962, 1964 Serology [108]
[66]
[110]
[111]
Kenya Human 1966e68 Nyanza, Kitui, Malindi, Northern Serology [64]
[67]
Somalia Human 1966 Mogadishu Serology [64]
Djibouti Human 1991e92 Djibouti city Serology [71]
Zambia Human 2014 Serology [68]
Angola Human 1960, 1971e72, 2016 Luanda, Bengo, 14 other localities PCR, Serology [101]
[102]
[103]
Mozambique Human 1957 Serology [69]
Egypt Human 1950s Serology [107]
Morocco Human 1968e69 Serology [83]
Birds Serology [83]
S. Boyer et al. / Microbes and Infection xxx (2018) 1e158localities in 1963e64; 53%), Benin (between Djougou and Savalou
in 1967; 44%), Togo (5 localities in 1964e66; 31%), Niger (Tera in
1965; 18%) [83], Chad (in 1954; 1.4%), Republic of Congo (in 1954;
0.4%) [104], Liberia [83,105] and Sierra Leone (14 localities in 1972;
5.3e14%) [106].
2.3. North Africa
Antibodies against ZIKV were found at low percentages in hu-
man samples collected in Egypt in 1950s [107] and in Morocco in
1968e69 [83].
2.4. Field-detections of ZIKV
2.4.1. In animals
ZIKV was isolated in a rhesus sentinel monkey (Macacca
mulatta) in Uganda [2] and in two other monkey species (Cercopi-
thecus aethiops, Erythrocebus patas) in Senegal. Antibodies against
ZIKV were detected by HI test in 24% of 41 wild mammals collected
in 1967e68 in Senegal (e.g. Chunickin, unpublished data) [83]. Anti-
ZIKV antibodies were detected in non-human primates in Nigeria
(83.3% in 1969), Ethiopia (50% in 1962 and 25% in 1964), CAR,
Democratic Republic of Congo, Gabon in 1979e80 and Liberia
[93,108,109,110,111]. Evidence for ZIKV epizootics were confirmed
by serological surveys of monkeys in Uganda in 1947, 1948, 1956,
1962, 1963, 1969 and 1970), Senegal in 1973 and 1976 and CAR in
1976 [111,112]. Antibodies against ZIKV have also been identified in
bats in Ethiopia and CAR, birds in Morocco and rodents in CAR
[109,111].
2.4.2. In mosquitoes
ZIKV was isolated for the first time in 1948 from a pool of Ae.
africanus collected in the Zika forest in Uganda [2]. The virus was
later isolated from the same vector species in 1956, 1962e64 and
1969e70 [62,113e115]. In Africa, ZIKV was detected in 26 mosquito
species (Table 1) mainly belonging to the genus Aedes, subgenera
Diceromyia, Stegomyia, and Aedimorphus [14]. Detailed entomo-
logical studies in southeastern Senegal allowed detection of ZIKV in
17 mosquito species during 22 years (including eight consecutive
years) over more than 40 years of arbovirus surveillance. Ae.
luteocephalus, Ae. africanus, Ae. furcifer, Ae. taylori and Ae. dalzieliPlease cite this article in press as: S. Boyer, et al., An overview of mosquito
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ZIKV in Senegal. In 2011, ZIKV was detected in mosquitoes collected
from multiple land covers, including forests, savannas, agricultural
land and villages around Kedougou. Inside villages, ZIKV was
mainly detected in Ae. vittatus and Ae. furcifer, which are principally
zoophagic species, meaning that they can act as bridge vectors
transmitting the virus from animals to humans. In addition,
repeated detection of ZIKV in pools of Ae. furcifer males [14] and
from adults obtained from field-collected eggs of Ae. bromeliae, Ae.
unilineatus and Ae. vittatus provide evidence of vertical trans-
mission (Diallo et al. unpublished data). ZIKV was detected in 12
mosquito species in Ivory Coast (mainly Ae. furcifer, Ae. africanus
and Ae. luteocaphalus; between 1973 and 1999), five species in
Burkina Faso (mainly Ae. luteocephalus and Ae. furcifer; in 1978 and
1983) [116], two species in CAR (Ae. africanus and Ae. opok in 1968,
1976 and 1979), Ae. albopictus in Gabon in 2007 [30] and Ae.
luteocephalus in Nigeria in 1969 [117].
Aedes aegypti was the only Aedes species found in Cabo Verde
during the ZIKV epidemic in 2015e16 (Diallo et al. unpublished
data). This species has been mostly found breeding in artificial
containers (including water storage and discarded containers) in
Africa, but some populations of the sylvatic Ae. aegypti formosus
breed in tree holes and other natural sites [118]. Aedes aegypti is
mainly considered an anthropophilic, indoor and day-time feeder
[119]. Aedes albopictus was the only species found infected during
the urban ZIKV epidemic in Gabon in 2007. Aedes furcifer, Ae.
luteocephalus, Ae. africanus, Ae. vittatus, Ae. dalzieli and Ae. taylori
are considered to be the main vectors of ZIKV in the sylvatic and
rural areas in West Africa, while Ae. africanus plays this role in
Central and Eastern Africa. These sylvatic and rural vectors breed
mainly in tree holes and fruit husks in forest galleries and savannah
land covers [118]. They are mainly primatophilic, crepuscular, and
outdoor feeders, but can be found feeding on humans. ZIKV has also
been occasionally isolated from awide range of mosquito species of
the genera Aedes, Culex, Eretmapodites and Mansonia.2.5. Vector competence studies
Only three published studies are available on vector competence
of mosquitoes from Africa for ZIKV (Table 2). The first study used a
population of Ae. aegypti from Nigeria which, after infection usingvectors of Zika virus, Microbes and Infection (2018), https://doi.org/
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Another population of Ae. aegypti from Kebemer (located at 140 km
from Dakar, Senegal) infected by intrathoracic viral injection, was
found to be highly competent to ZIKV with 88% of females trans-
mitting the virus at day 7 post infection (pi) [112]. However, when
theywere infected orally, 50.2% of the 221 of Ae. aegypti fromDakar,
57.6% of the 375 Ae. aegypti, 18.7% of the 300 Ae. unilineatus, 14.4% of
the 256 Ae. vittatus and 75.0% of the 60 Ae. luteocephalus from
Kedougou were susceptible to six different ZIKV strains. By
contrast, only a few mosquitoes of Ae. vittatus and Ae. luteocephalus
were able to transmit the virus with virus detected in mosquito
saliva [121].
3. Asia, the first emergence out of Africa
3.1. ZIKV circulation in Southeast Asia
In Asia, ZIKV had been suspected to circulate from 1954, in
Malaysia, Philippines, Thailand and Vietnam [107,122,123]. In
Malaysia in 1953, a seroprevalence survey confirmed a positive
seroneutralization in 25% of patients (six ZIKV-positive sera among
24 positive patients) [107]. In 1957, anti-ZIKV IgG/IgM antibodies
were detected in 13.3% of samples (143) but not in any children
under 10 years, suggesting a low circulation of ZIKV in Philippines
[122]. In Thailand in 1953e54, ZIKV circulation was suspected but
not serologically confirmed [123].
In the early 1980s, two serological studies in Indonesia revealed
evidence for “renewed” circulation of ZIKV in Asia [124,125]; a high
seroprevalence of 13% was reported in Central Java. Since 2009,
ZIKV cases were more frequently reported in Asia, probably in
relation to the outbreak on the Yap in 2007 in Micronesia, close to
Indonesia and Philippines [3]. This first outbreak in Yap outside
Africa and Asia affected more than 73% of ~11,000 residents. Thus,
in Asia, ZIKV circulation has been recorded in Thailand, Cambodia,
Indonesia, Philippines, Malaysia, and Vietnam in the last decade. In
2010, in Cambodia, an infection of a 3 year-old child who had never
traveled was reported in the central Kampong Speu province [13].
This case was confirmed by serology, PCR and sequencing,
corroborating the active circulation of ZIKV in Cambodia. Moreover,
a phylogenetic analysis demonstrated that ZIKV strains responsible
for the epidemic in Yap Island in 2007 and Cambodia in 2010 were
similar [13]. It has been suggested that these two strains came from
a common ancestor from South-East Asia, isolated in Malaysia in
1966 [13]. In Indonesia, ZIKVwas circulating in 2012 following local
infection of an Australian tourist with an Asian viral strain
[126,127]. In Philippines, ZIKV was isolated from a 15 year-old child
in a prospective longitudinal study in Cebu city [128]. The phylo-
genetic analysis of this virus showed that it was genetically close to
the virus isolated in Yap Island. In 2013, ZIKV was notified in
Thailand (detection by RT-PCR in urines) [129]. Additional studies
confirmed the active circulation of the Asian ZIKV lineage: in
Thailand [130,131], Indonesia [132], Malaysia [133] and Thailand
[134]. Lastly, a recent retrospective study reported five ZIKV-positive
sera in Cambodia from 2007, 2008, 2009 and 2015 [135], all
belonging to Asian lineage. ZIKV continues to circulate in Southeast
Asia with cases reported in Laos PTRs (ProMed), Vietnam (ProMed)
and Singapore where from August to November 2016, 455 cases of
infections were confirmed due to an Asian lineage [136]. There is no
mention of a potential enzootic cycle of ZIKV in Asia.
3.2. Asian ZIKV vectors and their vector competence
Unlike Africa, entomological studies in Asia concerning ZIKV
vectors are sporadic. One exception is the study in Malaysia where,
in July 1966, a ZIKV strain was isolated from 29 Ae. aegypti femalesPlease cite this article in press as: S. Boyer, et al., An overview of mosquito
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viral strain was then retrieved after inoculation into mice con-
firming its identity as an Asian lineage. Both Ae. aegypti [15] and Ae.
albopictus were suspected as vectors [124].
The first vector competence studies dated from 2012 in
Singapore [19] (Table 2). An F1 population of Ae. aegypti from
Singapore was infected with the Ugandan MR766 ZIKV strain.
Infection of midguts was detected from day 1 pi and reached 100%
at day 6 pi. Dissemination of ZIKV in salivary glands was confirmed
from day 4 pi and reached 100% at day 6 pi. The viral loads in
salivary glands varied between 6 and 7 Log 50% Tissue Culture
Infective Dose (TCID50)/mL after day 10 pi [19]. When examining F1
Ae. albopictus from Singapore infected with the Ugandan MR766
ZIKV strain, 73% of mosquitoes were able to transmit with virus
detected in mosquito saliva at day 7 pi. Viral loads in salivary glands
reached 5.96 LogTCID50/mL at day 10 pi [32].
In Hainan province in China, Culex quinquefasciatus has been
incriminated as a ZIKV vector [137]. An F1 population of this species
has been infected with a ZIKV strain SZ01 isolated from Samoa in
2016 [137]. Viral dissemination to salivary glands and ovaries was
shownwith a peak detected at day 8 pi, and the ZIKV titers reached
4.22e4.25 Log RNA copies/mL, with direct transmission of ZIKV
from infected mosquitoes to mice demonstrated [137] (Table 2).
This surprising result was not confirmed when using Cx. quinque-
fasciatus from Singapore [22]. Another mosquito, Ae. albopictuswas
also suspected as a vector of ZIKV. When infected with an Asian
ZIKV strain (H/PF13) from French Polynesia or an American strain
collected in Brazil (BE H 815744), Ae. albopictuswas less permissive
than Ae. aegypti that had a higher midgut infection, an earlier
presence of ZIKV in saliva and a higher susceptibility to the
American ZIKV strain [22] (Table 2).
4. The South Pacific islands, the start of the pandemic
4.1. The episode in the Pacific
In 2007, ZIKV emerged in the State of Yap, Federate States of
Micronesia. More than 5000 people were infected in a population
of 6700 [3,4]. From 2007 to 2013, ZIKV seemed to have disappeared
from the region. In 2013, ZIKV belonging to the Asian lineage
emerged in French Polynesia. Health authorities estimated that
more than 32,000 persons were infected (11.5% of the population).
In addition, a ZIKV seroprevalence study in 2014e2015 demon-
strated the presence of antibodies against ZIKV in 66% of the pop-
ulation sampled [5,138,139]. In French Polynesia, 42 cases of
Guillain-Barre and 8 cases of microcephaly in newborns were re-
ported [60,61]. From there, the spread of ZIKV in the Pacific region
was rapid; the islands composing the Pacific region are mainly
connected by airplanes facilitating the spread of the virus by
infected people. ZIKV outbreaks were subsequently reported in
New Caledonia in 2013, in Cook islands, Vanuatu, Fiji, Samoa, Sol-
omon islands in 2014 and in Tonga, the Marshall islands, the
Federate states of Micronesia and American Samoa in 2016
[5,140,141] (http://www.spc.int/phd/epidemics/). In New Caledo-
nia, between 2014 and 2015, more than 1500 cases were confirmed
[6]. Moreover, ZIKV circulation was still reported in New Caledonia
and American Samoa in 2017 (source DASS-NC and http://www.
spc.int/phd/epidemics/).
4.2. Mosquito vectors in the Pacific Islands
No ZIKV was detected from field-collected mosquitoes in the
Pacific region. Ae. aegypti could be considered as the main ZIKV
vector owing to its distribution covering most of the islands except
Futuna and other isolated islands [139,142]. The first description ofvectors of Zika virus, Microbes and Infection (2018), https://doi.org/
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introduction was probably facilitated by the migration of Euro-
peans and Asians [143]. Since then, the presence of Ae. aegypti and
the occurrence of a dengue epidemic were often associated. The
genetic characterization of this vector demonstrated a significant
population genetic structure at the Pacific scale [144]. Other Aedes
mosquitoes, potential ZIKV vectors, were reported in this part of the
world, Indeed, Ae. albopictus is present in the North and Central
Pacific, Aedes polynesiensis, in the eastern part and Aedes hensilli in
Micronesia. Ae. hensilli was considered the main vector of the ZIKV
outbreak on Yap Island in 2007 [145]. Again, the spread of these
species in the region is mainly facilitated by human travel and
commercial exchanges [139,142].
4.3. Vector competence
On Yap Island, densities of Ae. aegypti populations are low and Ae.
hensilli predominates making it the most likely ZIKV vector on this
island. Ae. hensilli mosquitoes were infected with ZIKV (MR 766,
African lineage). Infection was detected from day 8 pi and increased
with the blood-meal titer offered to mosquitoes. Viral dissemination
with virus detected in mosquito general cavity reached a maximum
of 22.6%, suggesting an efficient role of the midgut in limiting escape
of virus into the haemocoele [145] (Table 2).
In French Polynesia, two mosquito vectors were suspected, Ae.
aegypti and Ae. polynesiensis. Their vector competencewas assessed
for a ZIKV belonging to Asian/Pacific lineage (PF13/251013e18)
isolated from a patient in 2013 in Tahiti. When providing an in-
fectious blood meal at a titer of 107 TCID50/mL, Ae. aegypti appeared
to be easily infected by the virus (>85% of mosquitoes infected up to
day 21 pi). By contrast, Ae. polynesiensis showed an infection rate
lower than 36% at day 14 pi. Concerning viral dissemination, ZIKV
disseminated more in Ae. aegypti compared to Ae. polynesiensis.
When examining viral transmission by detecting the virus in Ae.
aegypti saliva, it increased over time (3% at day 6 pi and 73% at day
21 pi) (Table 2). These results suggest that ZIKV barely entered into
the salivary glands during the first days post-infection. For Ae.
polynesiensis, no ZIKV infectious particles were found until day
14 pi [23]. In addition, field-collected Cx. quinquefasciatus were
infected with the same ZIKV strain. A low infection rate and no
dissemination nor transmission was detected at day 21 pi [146]
(Table 2). In New Caledonia, the vector competence of Ae. aegypti
for ZIKV belonging to the Asian/Pacific lineage showed a high
infection rate of the vector, moderate viral dissemination and low
transmission of ZIKV until day 21 pi (Calvez et al. unpublished
data).
In Australia, Ae. aegypti is well established. Seven Australian
mosquito populations were infected with a blood meal containing
the African lineage ZIKV strain MR766 provided at a titer of
106.7 TCID50/mL. Infection of Ae. aegypti was moderate (57% at day
14 pi), the viral dissemination rate was moderate to high (70% at
day 14 pi) but the transmission efficiency was low (27% at day 14
pi). Ae. aegypti is a competent vector for ZIKV with, however, a low
ability to transmit the African lineage of ZIKV. Subsequently, Aedes
notoscriptus, Aedes procax and Aedes vigilax were tested using the
same ZIKV strain. The results indicated moderate infection rates for
all species, low dissemination and no transmission of ZIKV until day
14 pi (Table 2). Thus, Ae. aegypti is probably the main ZIKV vector
and the role of other Aedes spp. may be excluded [24]. Also, Culex
annulirostris, Cx. quinquefasciatus and Culex sitiens were tested for
vector competence to ZIKV/MR766. Low infection and no trans-
mission were observed for the Culex species suggesting a barrier to
viral dissemination from the midgut [24]. When using an Asian
lineage of ZIKV (strain Cambodia 2010), Ae. aegypti was again more
efficient in transmitting the virus than Aedes camptorhynchus andPlease cite this article in press as: S. Boyer, et al., An overview of mosquito
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Surprisingly, Ae. albopictus showed a high transmission rate of
76.9% whereas Cx. annulirostris and Cx. quinquefasciatus could not
transmit ZIKV [25] (Table 2).
5. An unprecedented outbreak in the Americas
5.1. Zika becomes an emerging global health threat
In 2014, the first autochthonous cases of ZIKV in the Americas
were detected in Easter Island, Chile, with 51 confirmed cases [7]. In
Brazil, ZIKV was first detected in symptomatic patients in March
2015, in the cities of Camaçari, Bahia [10] and in Natal, Rio Grande
do Norte [9], both cities located in the Northeast of Brazil. However,
a retrospective study analyzing samples from exanthematic (with
rash symptoms) cases diagnosed from January toMarch 2015 in Rio
de Janeiro, identified ZIKV suggesting that the virus was already
circulating in the Southeast region [49]. Some hypotheses were put
forward to explain the introduction of ZIKV into Brazil: (i) during
the Football World Cup competition in June and July 2014 [9] and
(ii) during the Canoe SpringWorld championship in August 2014, in
Rio de Janeiro [147]. However, phylogenetic and molecular clock
analyses estimated that ZIKV was introduced in Brazil in 2013,
before these two sporting events [148], and it is consistent with the
estimated timing of ZIKV introduction in the Americas [149,150]. By
the end of 2015, all Brazilian regions had already reported
autochthonous transmission with about 0.4e1.3 million suspected
cases [151].
During the ZIKV epidemic in Brazil, the number of reports of
microcephaly in newborns increased by 20-fold and reached 5400
cases [152]. The health authorities in Brazil also reported an in-
crease in the number of cases of Guillain-Barre syndrome from
2014 to 2015 [153] suggesting a possible link between ZIKV infec-
tion and neurological disorders. Based on the results of a systematic
review, WHO indicated that there was a scientific consensus that
ZIKV was a cause of microcephaly and Guillain-Barre syndrome
[60,154]. Early in 2016, WHO stated that infection with ZIKV was a
global health threat from February to November 2016 [155,156].
After the outbreak in Brazil, Colombiawas the second country to
report an epidemic, with an average of 5438 cases per week and a
peak of 6388 cases in February 2016 [157]. ZIKV then spread rapidly
to other countries in South America, Central America and in the
Caribbean [158,159]. By early 2017, almost all countries in Latin
America and the Caribbean reported active ZIKV circulation, with a
cumulative number of >170,000 confirmed and >510,000 sus-
pected cases [155]. ZIKV expanded its geographic range to North
America where imported ZIKV cases from South and Central
American countries were detected [160,161]. Autochthonous cases
were reported later in 2016 in Florida, United States (US) with 211
confirmed cases in January 2017 [162,163]. In November 2016,
Texas became the second US state to confirm a locally-transmitted
case of ZIKV with five autochthonous cases reported in January
2017 [163]. Until August 2017, 48 countries and territories
confirmed the autochthonous transmission of ZIKV [164] with an
estimation of 3e4 million cases. Until now, no specific treatment
and vaccine is available and ZIKV continues to spread worldwide in
areas where competent vectors are present [164]. Although the
number of Zika cases has declined markedly since the outbreak of
2016, virus surveillance must remain active.
5.2. Vector-borne transmission in Americas
During the recent outbreak, Ae. aegypti and Ae. albopictus were
recognized as the main vectors of ZIKV in the Americas [141]. ZIKV
was first detected in Ae. aegypti in Mexico in 2015e2016 [17,18]vectors of Zika virus, Microbes and Infection (2018), https://doi.org/
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including a male from Rio de Janeiro, which means that the vertical
and/or venereal transmission of ZIKV can occur in nature [16]. ZIKV
RNAs were detected in field-collected eggs of Ae. albopictus from
Brazil [31] (Table 1). Vertical transmissionwas also demonstrated in
the laboratory [47,48].
5.3. Ae. aegypti remains the most competent
In the laboratory, both Ae. aegypti and Ae. albopictus have been
shown to be efficient ZIKV vectors [20] (Table 2). The vector
competence of several populations of Ae. aegypti and Ae. albopictus
from the Caribbean, North America and South America was eval-
uated for the Asian lineage of ZIKV isolated from New Caledonia,
which showed 99.4% identity with ZIKV from Brazil. The results
showed that although susceptible to infection, Ae. aegypti and Ae.
albopictus are unexpectedly poorly competent vectors for ZIKV. In
contrast, Brazilian Ae. aegypti populations revealed high trans-
mission rates and efficiencies when orally challenged with ZIKV
isolated from Brazil [165,166].
Likewise, studies have revealed that American Ae. albopictus
populations are competent to transmit ZIKV, although their
competence is potentially dependent on the viral strain and the
geographic origin of the mosquito population [26,33]. Interestingly,
Mexican Ae. aegypti population showed higher rates of infection,
dissemination and transmission for African ZIKV strains than
American strains of the Asian lineage, responsible for the current
expansion of ZIKV [21]. The difference in vector competence for
ZIKV may be explained by the specific association of mosquito
populations and virus genotypes [167].
The flavivirus non-structural protein-1 (NS1) is abundantly
secreted into the serum of an infected host. NS1 can facilitate fla-
vivirus acquisition by vectors. It has been shown that the increased
infectivity of ZIKV and its high prevalence in Ae. aegyptimosquitoes
have been associated with a mutation at position 188 of the NS1
protein (A188V) providing a potential explanation for the success of
ZIKV transmission during the recent epidemics [168]. Potential
participation of other mosquito species present in Americas was
also investigated. However, it has been shown that Cx. pipiens and
Ae. triseriatus mosquitoes from US were not able to transmit ZIKV
[34]. Furthermore, Ae. taeniorhynchus from the US Gulf Coast was
also not susceptible [169]. Even at a high titer, Anopheles gambiae
and Anopheles stephensi from US were completely refractory to
ZIKV infection [170]. Notably, Aedes vexans mosquitoes from
northern Colorado are competent vectors of ZIKV although the
potential transmission appears to be low [171].
The role of mosquitoes of the Culex pipiens complex in ZIKV
transmission remains controversial. Most experimental infections
showed that various species of Culex were not competent to
transmit ZIKV. In the Americas, it includes Cx. pipiens [21,34,172],
Cx. quinquefasciatus [21,27,165,169,170,172,173] and Cx. tarsalis [21].
However, a single study conducted in Brazil reported that Cx.
quinquefasciatus is a potential ZIKV vector [28] (Table 2).
6. And Europe?
Together with CHIKV and DENV, ZIKV is transmitted by Aedes
mosquitoes, and the countries where these mosquitoes are present
could be potential sites for future Zika outbreaks. These locations
could include Southern Europe where Ae. albopictus has already
been involved in the local transmission of CHIKV and DENV. Trav-
elers returning from areas affected by CHIKV have been diagnosed
in several European countries [174,175]. In 2007, a CHIKV outbreak
occurred in northern Italy, affecting 240 people over a 2-month
period [176]. CHIKV hit Europe again in southern France in 2010,Please cite this article in press as: S. Boyer, et al., An overview of mosquito
10.1016/j.micinf.2018.01.0062014 [177]. After decades without detecting DENV, the disease is
back in Europe as demonstrated by the autochthonous cases re-
ported in Croatia in 2010 and in southern France in 2010, 2013, and
2015 [177].
Aedes aegypti was abundant in southern Europe and the Middle
East at the beginning of 20th century [178,179]. The species was
responsible for several Aedes-borne viruses outbreaks such as yel-
low fever (e.g. in Livorno in the central West Coast of Italy in 1804
[180]), dengue (in Greece in 1927e28 [181]). The vector dis-
appeared after the 1950s with the development of sanitization and
management of urban water collections and anti-malaria vector
control with DDT. The species has recently reinvaded European
territory, Madeira island in 2005 [182], and has recently been re-
ported around the Black Sea in southern Russia, Abkhazia, and
Georgia in 2004 [183].
The invasive species Ae. albopictus was recorded for the first
time in Europe in Albania in 1979 [184], then in Italy [185] intro-
duced by shipments of used tires from US [186]. It is now present in
more than 20 European countries [187]. Long-distance spread has
been associatedwith the transportation of eggs by the trade of used
tires [188]. Other local dispersal occurs by ground transportation
[189]. In Europe, Ae. albopictus colonizes mainly man-made con-
tainers such as flower plates, pots, tires. In France, Ae. albopictus
succeeded to establish in southeast of France in 2004 [190] and is
now in more than 33 French departments (http://solidarites-sante.
gouv.fr/sante-et-environnement/risques-microbiologiques-
physiques-et-chimiques/especes-nuisibles-et-parasites/article/
cartes-de-presence-du-moustique-tigre-aedes-albopictus-en-
france-metropolitaine). Given the extensive air travel between the
French overseas departments of French Guyana, Guadeloupe,
Martinique and France, the risk of local transmission of ZIKV in the
European area where the mosquito Ae. albopictus is widely
distributed, has been tested using mosquito experimental in-
fections. It has been shown that Ae. albopictus in southern France
was weakly competent for ZIKV infection requiring at least 14 days
pi to be excreted in mosquito saliva [29] (Table 2). Similarly, Italian
populations of Ae. albopictus showed susceptibility to ZIKV with
virus excreted in mosquito saliva at 11 days pi [35] (Table 2). Like
other Ae. albopictus populations, European populations presented a
lower vector competence than that of Ae. aegypti [29]. Ae. aegypti
fromMadeira, an autonomous region of Portugal, where the species
was introduced in 2005 [182] require only 9 days to transmit the
virus throughmosquito saliva [29] (Table 2). To date, it appears that
the risk for ZIKV in Europe is minimal based on the existing vector
competence studies.
7. Concluding remarks
ZIKV is transmitted among people primarily by the bite of
infected mosquitoes, Ae. aegypti and Ae. albopictus, or secondarily
through non-vector modes (i.e., vertical transmission, sexual
transmission, and blood transfusion). ZIKV is an African virus that
has emerged outside Africa after 1960mainly in Asia, more recently
it emerged in the Pacific Islands; Yap Island in 2007, French Poly-
nesia in 2013, and then the Americas since 2015. This virus was
mainly associated with mild symptoms but more severe symptoms
were described after the French Polynesian and American out-
breaks. To date, this emerging virus has raised questions that are
still unanswered. ZIKV transmission is characterized by low effi-
ciency of mosquito vectors, unusual importance and diversity of
non-vector-borne transmission, and the occurrence of severe cases
including severe congenital malformations.
High densities of human-biting mosquitoes, high human den-
sity naïve for ZIKV and suitable environmental conditions, were
mentioned as factors facilitating the rapid spread of the epidemic. Itvectors of Zika virus, Microbes and Infection (2018), https://doi.org/
S. Boyer et al. / Microbes and Infection xxx (2018) 1e1512is also legitimate to hypothesize that other anthropophilic vector
species may be involved in ZIKV transmission, for example Cx.
quinquefasciatus which are predominant in urban settings [165].
However, ZIKV has never been isolated from field-collected Cx.
quinquefasciatus and most studies reported an absence of ZIKV
transmission in laboratory
[21,24,25,34,165,168,170,172,173,191,192,193] except two studies
[28,137]. Pending these last results are confirmed by other studies,
mosquito control measures should remain focused on themosquito
Ae. aegypti which is also the vector of CHIKV and DENV, and much
more research effort should be allocated to fill the knowledge gaps
about this virus.
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